ClinConnect ClinConnect Logo
Search / Trial NCT02198378

Comparison of MEOPA + Paracetamol Versus Morphine Treatment in Acute Coronary Syndrome Analgesia.

Launched by UNIVERSITY HOSPITAL, TOULOUSE · Jul 22, 2014

Trial Information

Current as of October 02, 2025

Completed

Keywords

Premixed Nitrous Oxide And Oxygen Pain Prehospital Setting Acute Coronary Syndrome

ClinConnect Summary

The investigators wish to compare the use of morphine according to current recommendations with the use of MEOPA associated with intravenous paracetamol in the management of patients with STEMI. The investigators hypothesize that the association of MEOPA and paracetamol, which is easy to use in a pre-hospital setting, will give patients pain relief as effectively as morphine.

This alternative treatment would avoid the use of morphine, whose potentially damaging consequences on myocardial function have been suggested by experimental studies and by an observational study. The physician of th...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patient with STEMI \< 12 h treated before hospital admission and pain ≥ 4 on the numerical rating scale.
  • Exclusion Criteria:
  • Acute severe hemodynamic, respiratory or neurological failure
  • Heart failure: Killip class III and IV
  • Known allergy to morphine or nitrous oxide
  • Patient who has already received morphine or MEOPA before the arrival of the hospital team during the 4 hours preceding the pre-hospital intervention
  • Contraindications to nitrous oxide
  • Patient unable to assess pain intensity on the numerical rating scale
  • Patient under legal guardianship
  • Pregnancy
  • Patient transported by air ambulance

About University Hospital, Toulouse

The University Hospital of Toulouse is a leading academic medical center dedicated to advancing healthcare through innovative research and clinical trials. With a strong emphasis on patient-centered care, the hospital integrates cutting-edge scientific inquiry with comprehensive clinical services. Its multidisciplinary team of healthcare professionals collaborates with renowned researchers to facilitate pioneering studies across various medical fields, aiming to enhance treatment options and improve patient outcomes. As a prominent institution in the region, the University Hospital of Toulouse is committed to fostering an environment of excellence in both education and research within the healthcare community.

Locations

Nancy, France

Nantes, France

Poitiers, France

Tours, France

Lille, France

Toulouse, France

Limoges, France

Marseille, France

Bobigny, France

Pontoise, France

Bordeaux, France

Valence, France

Montpellier, France

Corbeil Essonnes, France

Contamine Sur Arve, France

Chateauroux, France

Chartres, France

Clermont Ferrand, France

Agen, France

Besançon, France

Bourg En Bresse, France

Chambéry, France

Clichy, France

Dijon, France

Foix, France

Garches, France

Grenoble, France

La Roche Sur Yon, France

Lyon, France

Melun, France

Metz, France

Nice, France

Paris, France

Paris, France

Paris, France

Pringy, France

Saint Gaudens, France

Toulon, France

Vienne, France

Saint Denis, Réunion

Patients applied

0 patients applied

Trial Officials

Sandrine Charpentier, PH,MD

Principal Investigator

CHU Toulouse

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials